Atlas Trials

Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients

Clinical trial NCT01861938 · WITHDRAWN

Trial details

NCT number
NCT01861938
Sponsor
Hadassah Medical Organization
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
High Risk HLA-A2+ MelanomaMetastatic Disease
Start date
2017-03-01
Primary completion
2019-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.